Program Description & Educational Objectives

In this activity, experts in managing HIV discuss considerations for initiating antiretroviral therapy, including the latest guideline recommendations.

Upon completion of this activity, participants will be able to:

• Generalize evidence for earlier initiation of antiretroviral therapy in patients with HIV to practice
• Apply recent clinical evidence to the selection of front-line treatment regimens in patients with HIV
• Develop individualized, long-term treatment strategies for patients with HIV

Target Audience

This activity has been designed to meet the educational needs of HIV specialists, nurses, pharmacists, and other clinicians involved in managing patients with HIV.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: July 02, 2010 - July 01, 2011
Time to Complete: 30 minutes

Faculty & Disclosure

Course Director and Moderator

Paul Sax, MD
Clinical Director, HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Paul Sax, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for Abbott Laboratories; Bristol-Myers Squibb Company; Gilead Sciences Medical Affairs; Merck & Co., Inc.; Tibotec, Inc.; and ViiV Healthcare.

Grant/Research Support from Gilead Sciences Medical Affairs; Merck & Co., Inc.; and Tibotec, Inc.

Interviewee

David Wohl, MD
Associate Professor of Medicine
School of Medicine
University of North Carolina
Site Leader, AIDS Clinical Trials Unit – Chapel Hill
Co-Director of HIV Services
North Carolina Department of Corrections
Chapel Hill, North Carolina

David Wohl, MD, has a financial interest/relationship or affiliation in the form of:

Grant/Research Support from Abbott Laboratories; GlaxoSmithKline; Merck & Co., Inc.; and Tibotec, Inc.

Honoraria from Abbott Laboratories; Bristol-Myers Squibb Company; Gilead Sciences Medical Affairs; GlaxoSmithKline; Merck & Co., Inc.; and Tibotec, Inc.

Advisory Board for Abbott Laboratories and Gilead Sciences Medical Affairs.

Content Director

Annette Wiggins
PVI, PeerView Institute for Medical Education, Inc.

Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.

All additional planning committee members, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University School of Pharmacy staff have no relationships to disclose.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University School of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University School of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University School of Pharmacy designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

Purdue University Continuing Nursing Education is approved as a provider of continuing nursing education by the Indiana State Nurses Association. ISNA is accredited as an approver of continuing education in nursing by the Commission on Accreditation of the American Nurses Credentialing Center. Code #CNEP-09-53.

This program has been approved for 0.5 contact hour(s).

Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.

Pharmacists

Purdue University School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Program Number (UPN): 0018-9999-10-134-H01-P, 0.5 contact hours (0.05 CEUs).

This activity is supported by an educational grant from